Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Impact of COVID-19 on US Insurance and Global Reinsurance Outlooks
ModeratorStefan Holzberger – Chief Rating Officer, AM Best
PanelistsJohn Andre – Managing Director, AM Best
Ken Johnson – Managing Director, AM BestSally Rosen – Senior Director, AM Best
Carlos Wong Fupuy – Senior Director, AM Best
Market Segment Outlook – US Commercial Lines
Headwinds Tailwinds
Economic conditions driving lower
premiums and subsequently earnings
Solid risk-adjusted
capitalization and liquidity
Impact of lower asset values on
capital and surplusRates had been increasing pre-COVID crisis
Lower than expected interest rates for the
foreseeable future Potential for reduced loss exposures
Elevated “Other Liability” lossesEnhanced underwriting and ERM tools
driven by innovation
Potential Business Interruption losses
AM Best has revised the Stable Outlook on the US Commercial Lines Segment to Negative
4
Change in Sub-Segment Outlooks – US Commercial Lines
Segment Outlook
Workers Compensation Negative
Excess & Surplus Lines Negative
Commercial Auto Negative
Professional Liability Negative
Medical Professional Liability Negative
Title Negative
Surety Negative
5
Market Segment Outlook – US Personal Lines
Headwinds Tailwinds
Elevated frequency & severity of weather
patterns Strong risk-adjusted capitalization
Potential reinsurance pricing pressures –
particularly loss affected regionsOn-going underwriting and pricing discipline
Evolving customer and agent expectationsCore property performance
(excluding weather events)
Greater-than-expected operating impact
from COVID-19
Ample reinsurance capacity – increased use
of innovative/flexible structures
Continued equity market volatility Advanced pricing sophistication
AM Best has maintained the Stable Outlook on the Personal Lines sector
6
Market Segment Outlook – US Life/Annuity
Headwinds Tailwinds
Significant market volatility in
US and Global economyStrong risk-adjusted capitalization
Increased expectations for deterioration in
operating performance trendsImproved company-wide liquidity profiles
Accelerated negative impact from markets
on both assets and liabilities
On-going product de-risking and
pricing discipline
Concentrated investment strategiesRegular stress testing performed as part of
improving ERM profiles
Concentrated product strategies Innovation in U/W and customer experience
limits need for face-to-face interaction
AM Best has revised the Stable Outlook on the US Life/Annuity sector to Negative
9
Market Segment Outlook – US Health
Headwinds Tailwinds
Increase in severity of medical claims Strong risk-adjusted capitalization
Decline in premiums from layoff/furloughs Trend of strong earnings
Potential delays in payment from customersPrior to COVID-19, broad based trend of
lower utilization and medical cost trends
Temporary increase in financial leverage Suspension of non-essential care
Investment income & credit riskMajority who test positive are not
hospitalized
AM Best has maintained the Stable Outlook on the US Health sector
12
Sub-Segment Outlooks – US Health
Segment Outlook
Supplemental Health Stable
Disability Insurance Negative
Long Term Care Insurance Negative
13
Market Segment Outlook – Global Reinsurance
Headwinds Tailwinds
Uncertainty regarding reinsured losses First loss estimates seem manageable
Recent volatility in investment portfolioFed / Central Banks stimulus packages,
potential for recovery post-crisis
Low interest rate environment Strong balance sheet positions
Economic recessionary pressuresHardening pricing condition potential for
reduced claims activity
Reduced third party capital appetite Permanence of traditional capital
AM Best has maintained the outlook on the Global Reinsurance sector at Stable
15
Market Segment Outlook – Global Non-Life Reinsurance
Headwinds Tailwinds
Specialty lines of business potentially affected Existence of exclusions and sub-limits
Unrealized losses in investment portfolioHigh credit quality in fixed income portfolios
Low equity component
Low interest rate environment Strong balance sheet positions
Pressure on top line due to recessionary
pressures
1/1 and 4/1 renewals successful
Potential for reduced claims activity
Reduced third party capital appetite
Liquidity pressures
Hardening pricing conditions
(CAT, casualty, specialty)
AM Best has maintained the outlook on the Global Non-Life Reinsurance sector at Stable
16
Market Segment Outlook – Global Life Reinsurance
Headwinds Tailwinds
Key biometric risk – mortality, to be affectedFocus on working age groups, less vulnerable
to COVID-19
Uncertainty regarding ultimate lossesCurrent estimates still well below 1:200 year
pandemic scenario
Low interest rate environment Good quality investment portfolios
Asset volatility Tight asset liability matching
Focus on biometric risks only
Morbidity exposuresRelatively small risk component
offsetting non-COVID claims activity
AM Best has maintained the outlook on the Global Life Reinsurance sector at Stable
17
Sub-Segment Outlooks – Global Reinsurance
Segment Outlook
Global Non-Life Reinsurance Stable
Global Life Reinsurance Stable
18
© AM Best Company, Inc. (AMB) and/or its licensors and affiliates. All rights reserved. ALL INFORMATION CONTAINED HEREIN IS PROTECTED BY COPYRIGHT LAW AND
NONE OF SUCH INFORMATION MAY BE COPIED OR OTHERWISE REPRODUCED, REPACKAGED, FURTHER TRANSMITTED, TRANSFERRED, DISSEMINATED,
REDISTRIBUTED OR RESOLD, OR STORED FOR SUBSEQUENT USE FOR ANY SUCH PURPOSE, IN WHOLE OR IN PART, IN ANY FORM OR MANNER OR BY ANY
MEANS WHATSOEVER, BY ANY PERSON WITHOUT AMB’s PRIOR WRITTEN CONSENT. All information contained herein is obtained by AMB from sources believed by it to be
accurate and reliable. AMB does not audit or otherwise independently verify the accuracy or reliability of information received or otherwise used and therefore all information
contained herein is provided “AS IS” without warranty of any kind. Under no circumstances shall AMB have any liability to any person or entity for (a) any loss or damage in whole
or in part caused by, resulting from, or relating to, any error (negligent or otherwise) or other circumstance or contingency within or outside the control of AMB or any of its directors,
officers, employees or agents in connection with the procurement, collection, compilation, analysis, interpretation, communication, publication or delivery of any such information, or
(b) any direct, indirect, special, consequential, compensatory or incidental damages whatsoever (including without limitation, lost profits), even if AMB is advised in advance of the
possibility of such damages, resulting from the use of or inability to use, any such information. The credit ratings, financial reporting analysis, projections, and other observations, if
any, constituting part of the information contained herein are, and must be construed solely as, statements of opinion and not statements of fact or recommendations to purchase,
sell or hold any securities, insurance policies, contracts or any other financial obligations, nor does it address the suitability of any particular financial obligation for a specific
purpose or purchaser. Credit risk is the risk that an entity may not meet its contractual, financial obligations as they come due. Credit ratings do not address any other risk,
including but not limited to, liquidity risk, market value risk or price volatility of rated securities. AMB is not an investment advisor and does not offer consulting or advisory services,
nor does the company or its rating analysts offer any form of structuring or financial advice. NO WARRANTY, EXPRESS OR IMPLIED, AS TO THE ACCURACY, TIMELINESS,
COMPLETENESS, MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OF ANY SUCH RATING OR OTHER OPINION OR INFORMATION IS GIVEN OR
MADE BY AMB IN ANY FORM OR MANNER WHATSOEVER. Each credit rating or other opinion must be weighed solely as one factor in any investment or purchasing decision
made by or on behalf of any user of the information contained herein, and each such user must accordingly make its own study and evaluation of each security or other financial
obligation and of each issuer and guarantor of, and each provider of credit support for, each security or other financial obligation that it may consider purchasing, holding or selling.
20